Abstract session: NAFLD - Non invasive assessment

 Metabolism, alcohol and toxicity

Room 3
English
Abstract session
27 August 2020 11:00 - 12:30


Presentations

Title Time

Add to Calendar

AS096 Repeated measures of FIB-4 improve prediction of severe liver disease: population-based cohort study of 40,729 individuals
27 August 2020 11:00 - 11:15
AS097 Utility of magnetic resonance elastography in accurate identification of candidates for pharmacologic treatment of NASH related fibrosis: A prospective cohort study
27 August 2020 11:15 - 11:30
AS098 Machinelearning outperforms existing non-invasive tests as screening tool for liver fibrosis in the general population
27 August 2020 11:30 - 11:45
AS100 Progression of liver stiffness and the development of cirrhosis in histologically characterized patients with non-alcoholic fatty liver disease
27 August 2020 11:45 - 12:00
AS101 Convolutional neural networks of H&E-stained biopsy images accurately quantify histologic features of nonalcoholic steatohepatitis
27 August 2020 12:00 - 12:15
AS102 Serum levels of miR-34a to rule-out NAFLD in healthy subjects and identify NAFLD patients with active NASH (NAS>=4) and significant liver fibrosis (F>=2)
27 August 2020 12:15 - 12:30